D2C7-IT With Atezolizumab for Recurrent Gliomas

Clinical trial NCT04160494 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04160494
Sponsor: Darell Bigner
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma

Start date: 2020-02-25
Primary completion: 2024-06-28
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.